Beta Bionics, Inc. Increase (Decrease) in Other Noncurrent Liabilities
Beta Bionics, Inc. (BBNX) reported Increase (Decrease) in Other Noncurrent Liabilities of $82.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-07-29
- Beta Bionics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-06-30 was $71.00K.
- Beta Bionics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-03-31 was $11.00K.
- Beta Bionics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-12-31 was $342.00K.
- Beta Bionics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-30 was $194.00K.
- Beta Bionics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2025 was $1.55M.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $71.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $82.00K 10-Q · filed 2026-07-29 | $424.00K derived: sum of 3 quarters · filed 2026-07-29 | $618.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $11.00K 10-Q · filed 2026-04-21 | $353.00K derived: sum of 2 quarters · filed 2026-04-21 | $547.00K derived: sum of 3 quarters · filed 2026-04-21 | |
| 2025-12-31 | $342.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $536.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.55M 10-K · filed 2026-02-24 | |
| 2025-09-30 | $194.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $1.21M 10-Q · filed 2025-10-28 | ||
| 2025-06-30 | $1.01M 10-Q · filed 2026-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |